chr22-20709982-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_058004.4(PI4KA):c.6099G>A(p.Ala2033=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00377 in 1,613,212 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 4 hom., cov: 29)
Exomes 𝑓: 0.0039 ( 9 hom. )
Consequence
PI4KA
NM_058004.4 synonymous
NM_058004.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.42
Genes affected
PI4KA (HGNC:8983): (phosphatidylinositol 4-kinase alpha) This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 22-20709982-C-T is Benign according to our data. Variant chr22-20709982-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 779291.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-20709982-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.42 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00274 (417/152310) while in subpopulation NFE AF= 0.00526 (358/68032). AF 95% confidence interval is 0.00481. There are 4 homozygotes in gnomad4. There are 193 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PI4KA | NM_058004.4 | c.6099G>A | p.Ala2033= | synonymous_variant | 53/55 | ENST00000255882.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PI4KA | ENST00000255882.11 | c.6099G>A | p.Ala2033= | synonymous_variant | 53/55 | 1 | NM_058004.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00274 AC: 417AN: 152192Hom.: 4 Cov.: 29
GnomAD3 genomes
AF:
AC:
417
AN:
152192
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00225 AC: 563AN: 250714Hom.: 2 AF XY: 0.00245 AC XY: 333AN XY: 135690
GnomAD3 exomes
AF:
AC:
563
AN:
250714
Hom.:
AF XY:
AC XY:
333
AN XY:
135690
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00388 AC: 5666AN: 1460902Hom.: 9 Cov.: 30 AF XY: 0.00393 AC XY: 2857AN XY: 726844
GnomAD4 exome
AF:
AC:
5666
AN:
1460902
Hom.:
Cov.:
30
AF XY:
AC XY:
2857
AN XY:
726844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00274 AC: 417AN: 152310Hom.: 4 Cov.: 29 AF XY: 0.00259 AC XY: 193AN XY: 74456
GnomAD4 genome
AF:
AC:
417
AN:
152310
Hom.:
Cov.:
29
AF XY:
AC XY:
193
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | PI4KA: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at